Oncology Therapy Devices

Oncology therapy devices represent a rapidly evolving field in cancer treatment, offering innovative solutions such as surgical robotics, ablation systems, targeted radiation devices, and implantable drug delivery systems. However, conducting clinical trials for these devices presents unique challenges, from complex regulatory pathways to specialized patient recruitment and long-term outcome monitoring.

Meditronics provides end-to-end clinical trial services for oncology therapy devices, ensuring efficient study execution, regulatory compliance, and high-quality data collection. Our expertise spans early feasibility studies to post-market surveillance, with a focus on safety, efficacy, and real-world performance.

End-to-End Clinical Trial Services

Comprehensive Study Design & Budget Optimization Services

We provide tailored clinical trial solutions for all phases of oncology device development:

Early Feasibility & First-in-Human (FIH) Studies
Protocol development with Key Opinion Leader (KOL) input; Small-scale safety and feasibility assessments; Procedural standardization for novel devices
Pivotal Trials
Large-scale efficacy studies with long-term follow-up planning; Cost-effective budget management for complex oncology trials; Strategic endpoint selection for regulatory success
Post-Market Surveillance (PMS)
Real-world evidence study design and execution; Long-term safety monitoring programs; Risk-based monitoring approaches to optimize costs

Global Regulatory & Ethical Compliance Expertise

Our regulatory team provides end-to-end support:

Pre-submission strategy development for FDA (PMA, De Novo, Breakthrough Device), EU MDR, and other global markets
Ethics committee preparation and submission
ISO 14155 compliance assurance for medical device trials
Data Monitoring Committee (DMC) establishment and management.

Specialized Site Selection & Investigator Training

We ensure optimal trial execution through:

Global network of premier oncology centers with expertise in surgical oncology, interventional radiology, and radiation therapy.
Comprehensive investigator training programs including hands-on device training workshops, standardized procedural protocols and GCP and protocol-specific training.

Targeted Patient Recruitment & Retention Solutions

Our oncology-specific recruitment services include:

Precision patient identification using strict eligibility criteria: Cancer stage and type; Prior treatment history; Biomarker status
Specialized recruitment strategies for challenging populations: Cancer stage and type; Rare cancer indications; Elderly oncology patients
Innovative retention programs: Remote monitoring solutions; Patient support initiatives; Digital engagement tools

Rigorous Clinical Monitoring & Data Management

We maintain the highest data quality standards through:

Risk-based monitoring (RBM) strategies tailored to oncology trials
Centralized imaging and biomarker review by oncology specialists
Advanced electronic data capture (EDC) systems with real-time safety alerts, automated query resolution, and integrated imaging data management
Standardized documentation including device placement parameters, treatment delivery metrics and adverse event reporting

Comprehensive Post-Treatment Follow-Up Programs

Our long-term outcome assessment services include:

Short-term follow-up (30-90 days): Procedure-related complication tracking, initial tumor response assessment.
Mid-term follow-up (6-24 months): Local recurrence monitoring, progression-free survival analysis.
Long-term follow-up (3-5+ years): Overall survival data collection, quality of life assessments, late-stage complication monitoring.

Oncology Therapy Device Categories We Serve

We support trials for:

Minimally Invasive Surgical Devices (robotic-assisted systems, laparoscopic tools)
Ablation & Embolization Systems (RF/microwave/cryoablation, TACE)
Radiotherapy & Brachytherapy Devices
Implantable Drug Delivery & Monitoring Systems

Why Partner with Meditronics for Oncology Therapy Device Trials?

1. Regulatory & Compliance Excellence

Pre-submission strategy (FDA IDE, CE Mark, NMPA approvals)
Ethics committee & regulatory agency interactions
Post-market clinical follow-up (PMCF) studies

2. Operational Efficiency & Site Management

Fast site activation with leading cancer research hospitals
Investigator training & procedural standardization
Centralized imaging & pathology review

3. Advanced Data & AI Analytics

Radiomics & AI-assisted tumor response assessment.
Real-world evidence (RWE) integration for post-market studies.

Partner with Meditronics to accelerate your oncology device trials and achieve successful market entry.

Online Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Need More Information or Request A Quotation?

Send us a request